Anesthesia Will Give Birth To Robust Growth at Mednax (MD) - Jefferies
Tweet Send to a FriendGet Alerts MD Hot Sheet
Price: $92.97 --0%
Rating Summary:
8 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 6
Rating Summary:
8 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 6
Trade MD Now!
Today analysts at Jefferies reiterated their Buy rating on Mednax and raised their price target to $88 from $81.
Mednax (MD) is one of Jefferies top picks given their belief that the company's push to aggressively expand its anesthesiology business will drive robust growth over the next several years that is not yet adequately reflected in the stock's valuation.
“MD's push to grow anesthesiology to the size of its pediatric business suggests a projected 5-year revenue CAGR of ~17%. Given that anesthesiology is a large segment (with 48,000+ physicians) comprised mostly of good-sized practice groups (basedon revenues), we believe MD's goal is attainable.” said analyst Brian Tanquilut.
For an analyst ratings summary and ratings history on Mednax click here. For more ratings news on Mednax click here.
Shares of Mednax closed at $75.29 yesterday, with a 52 week range of $59.24-$76.04.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Mednax (MD) is one of Jefferies top picks given their belief that the company's push to aggressively expand its anesthesiology business will drive robust growth over the next several years that is not yet adequately reflected in the stock's valuation.
“MD's push to grow anesthesiology to the size of its pediatric business suggests a projected 5-year revenue CAGR of ~17%. Given that anesthesiology is a large segment (with 48,000+ physicians) comprised mostly of good-sized practice groups (basedon revenues), we believe MD's goal is attainable.” said analyst Brian Tanquilut.
For an analyst ratings summary and ratings history on Mednax click here. For more ratings news on Mednax click here.
Shares of Mednax closed at $75.29 yesterday, with a 52 week range of $59.24-$76.04.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Wedbush Downgrades XenoPort (XNPT) to Neutral
- Ryder Systems (R) Can Easily Ride Higher - FBR Capital
- Wells Fargo Starts Taylor Morrison Home (TMHC) at Outperform
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeRelated Entities
Jefferies & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
